Table 1.

Demographic and clinical characteristics of the study groups.

	H	SZ
Male/female, n	18/0	18/0
Age (years)	42 ± 13	38 ± 14
Smoking status (yes/no)	14/4	9/9
Onset age (years)		25.14 ± 12.45
Duration (years)		13.03 ± 9.76
Positive and negative syndrome scale:
Positive		21.11 ± 5.43
Negative		28.50 ± 5.19
General		46.61 ± 10.53
Total		95.06 ± 17.31
Hallucinations		2.50 ± 1.29
Chlorpromazine equivalents (mg)		583.50 ± 217.03